Answers are grounded in this paper and cite their sources.
Researchers discover immune-induced TCR-like antibodies that suppress T cell response in mice, suggesting new strategies for autoimmune disease treatment.
Antigen-specific regulation of T cell response is crucial for limiting hyperimmune response. However, the molecular mechanisms governing specific immune regulation remain unclear. In this study, we discover that antibodies specific to the antigen peptide-MHC class II complex are produced during helper T cell responses to various antigens, including hen egg lysozyme and proteolipid protein peptide. These antibodies specifically inhibit T cell receptor (TCR) recognition of MHC class II molecules presenting specific antigen peptide. We term these antibodies ‘immune-induced TCR-like antibodies’ or iTabs. Immunization with peptides containing flanking residues induces iTabs whereas immunization with peptides lacking flanking residues does not. Furthermore, we show that immunization with iTab-inducible peptide or iTab treatment suppress autoimmune disease development in a mouse model of experimental autoimmune encephalomyelitis. Thus, our findings provide a strategy for suppressing antigen-specific helper T cell responses using specific peptides, potentially controlling autoimmune diseases.
No takes yet. Share an insight, caveat, or question.
Kishida et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: